Global Biotechnological Drugs Market Research Report 2025(Status and Outlook)
Report Overview
Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
This report provides a deep insight into the global Biotechnological Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biotechnological Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biotechnological Drugs market in any manner.
Global Biotechnological Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy?s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Market Segmentation (by Type)
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Market Segmentation (by Application)
Tumor
Autoimmune Disease
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biotechnological Drugs Market
Overview of the regional outlook of the Biotechnological Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biotechnological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biotechnological Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
This report provides a deep insight into the global Biotechnological Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biotechnological Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biotechnological Drugs market in any manner.
Global Biotechnological Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy?s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Market Segmentation (by Type)
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Market Segmentation (by Application)
Tumor
Autoimmune Disease
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biotechnological Drugs Market
Overview of the regional outlook of the Biotechnological Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biotechnological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biotechnological Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biotechnological Drugs
1.2 Key Market Segments
1.2.1 Biotechnological Drugs Segment by Type
1.2.2 Biotechnological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTECHNOLOGICAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biotechnological Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Biotechnological Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTECHNOLOGICAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biotechnological Drugs Product Life Cycle
3.3 Global Biotechnological Drugs Sales by Manufacturers (2020-2025)
3.4 Global Biotechnological Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biotechnological Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biotechnological Drugs Market Competitive Situation and Trends
3.8.1 Biotechnological Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biotechnological Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOTECHNOLOGICAL DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Biotechnological Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTECHNOLOGICAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biotechnological Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biotechnological Drugs Market
5.7 ESG Ratings of Leading Companies
6 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biotechnological Drugs Sales Market Share by Type (2020-2025)
6.3 Global Biotechnological Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Biotechnological Drugs Price by Type (2020-2025)
7 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biotechnological Drugs Market Sales by Application (2020-2025)
7.3 Global Biotechnological Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Biotechnological Drugs Sales Growth Rate by Application (2020-2025)
8 BIOTECHNOLOGICAL DRUGS MARKET SALES BY REGION
8.1 Global Biotechnological Drugs Sales by Region
8.1.1 Global Biotechnological Drugs Sales by Region
8.1.2 Global Biotechnological Drugs Sales Market Share by Region
8.2 Global Biotechnological Drugs Market Size by Region
8.2.1 Global Biotechnological Drugs Market Size by Region
8.2.2 Global Biotechnological Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Biotechnological Drugs Sales by Country
8.3.2 North America Biotechnological Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biotechnological Drugs Sales by Country
8.4.2 Europe Biotechnological Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biotechnological Drugs Sales by Region
8.5.2 Asia Pacific Biotechnological Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biotechnological Drugs Sales by Country
8.6.2 South America Biotechnological Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biotechnological Drugs Sales by Region
8.7.2 Middle East and Africa Biotechnological Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOTECHNOLOGICAL DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Biotechnological Drugs by Region(2020-2025)
9.2 Global Biotechnological Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biotechnological Drugs Production
9.4.1 North America Biotechnological Drugs Production Growth Rate (2020-2025)
9.4.2 North America Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biotechnological Drugs Production
9.5.1 Europe Biotechnological Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biotechnological Drugs Production (2020-2025)
9.6.1 Japan Biotechnological Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biotechnological Drugs Production (2020-2025)
9.7.1 China Biotechnological Drugs Production Growth Rate (2020-2025)
9.7.2 China Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 3SBIO
10.1.1 3SBIO Basic Information
10.1.2 3SBIO Biotechnological Drugs Product Overview
10.1.3 3SBIO Biotechnological Drugs Product Market Performance
10.1.4 3SBIO Business Overview
10.1.5 3SBIO SWOT Analysis
10.1.6 3SBIO Recent Developments
10.2 Anhui Anke Biotechnology
10.2.1 Anhui Anke Biotechnology Basic Information
10.2.2 Anhui Anke Biotechnology Biotechnological Drugs Product Overview
10.2.3 Anhui Anke Biotechnology Biotechnological Drugs Product Market Performance
10.2.4 Anhui Anke Biotechnology Business Overview
10.2.5 Anhui Anke Biotechnology SWOT Analysis
10.2.6 Anhui Anke Biotechnology Recent Developments
10.3 Beijing SL Pharmaceutical
10.3.1 Beijing SL Pharmaceutical Basic Information
10.3.2 Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
10.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Product Market Performance
10.3.4 Beijing SL Pharmaceutical Business Overview
10.3.5 Beijing SL Pharmaceutical SWOT Analysis
10.3.6 Beijing SL Pharmaceutical Recent Developments
10.4 Biotech Pharmaceutical
10.4.1 Biotech Pharmaceutical Basic Information
10.4.2 Biotech Pharmaceutical Biotechnological Drugs Product Overview
10.4.3 Biotech Pharmaceutical Biotechnological Drugs Product Market Performance
10.4.4 Biotech Pharmaceutical Business Overview
10.4.5 Biotech Pharmaceutical Recent Developments
10.5 Cadila Healthcare
10.5.1 Cadila Healthcare Basic Information
10.5.2 Cadila Healthcare Biotechnological Drugs Product Overview
10.5.3 Cadila Healthcare Biotechnological Drugs Product Market Performance
10.5.4 Cadila Healthcare Business Overview
10.5.5 Cadila Healthcare Recent Developments
10.6 Celgen Biopharma
10.6.1 Celgen Biopharma Basic Information
10.6.2 Celgen Biopharma Biotechnological Drugs Product Overview
10.6.3 Celgen Biopharma Biotechnological Drugs Product Market Performance
10.6.4 Celgen Biopharma Business Overview
10.6.5 Celgen Biopharma Recent Developments
10.7 Celltrion
10.7.1 Celltrion Basic Information
10.7.2 Celltrion Biotechnological Drugs Product Overview
10.7.3 Celltrion Biotechnological Drugs Product Market Performance
10.7.4 Celltrion Business Overview
10.7.5 Celltrion Recent Developments
10.8 Dr Reddy?s
10.8.1 Dr Reddy?s Basic Information
10.8.2 Dr Reddy?s Biotechnological Drugs Product Overview
10.8.3 Dr Reddy?s Biotechnological Drugs Product Market Performance
10.8.4 Dr Reddy?s Business Overview
10.8.5 Dr Reddy?s Recent Developments
10.9 GeneScience Pharmaceuticals
10.9.1 GeneScience Pharmaceuticals Basic Information
10.9.2 GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
10.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Product Market Performance
10.9.4 GeneScience Pharmaceuticals Business Overview
10.9.5 GeneScience Pharmaceuticals Recent Developments
10.10 Hisun Pharma
10.10.1 Hisun Pharma Basic Information
10.10.2 Hisun Pharma Biotechnological Drugs Product Overview
10.10.3 Hisun Pharma Biotechnological Drugs Product Market Performance
10.10.4 Hisun Pharma Business Overview
10.10.5 Hisun Pharma Recent Developments
10.11 Jiangsu Sihuan Bioengineering
10.11.1 Jiangsu Sihuan Bioengineering Basic Information
10.11.2 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
10.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Market Performance
10.11.4 Jiangsu Sihuan Bioengineering Business Overview
10.11.5 Jiangsu Sihuan Bioengineering Recent Developments
10.12 Novartis (Sandoz)
10.12.1 Novartis (Sandoz) Basic Information
10.12.2 Novartis (Sandoz) Biotechnological Drugs Product Overview
10.12.3 Novartis (Sandoz) Biotechnological Drugs Product Market Performance
10.12.4 Novartis (Sandoz) Business Overview
10.12.5 Novartis (Sandoz) Recent Developments
10.13 Pfizer (Hospira)
10.13.1 Pfizer (Hospira) Basic Information
10.13.2 Pfizer (Hospira) Biotechnological Drugs Product Overview
10.13.3 Pfizer (Hospira) Biotechnological Drugs Product Market Performance
10.13.4 Pfizer (Hospira) Business Overview
10.13.5 Pfizer (Hospira) Recent Developments
10.14 Shanghai Lansheng Guojian Pharmaceutical
10.14.1 Shanghai Lansheng Guojian Pharmaceutical Basic Information
10.14.2 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
10.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Market Performance
10.14.4 Shanghai Lansheng Guojian Pharmaceutical Business Overview
10.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
10.15 Shenzhen Neptunus Interlong Bio-Technique
10.15.1 Shenzhen Neptunus Interlong Bio-Technique Basic Information
10.15.2 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
10.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Market Performance
10.15.4 Shenzhen Neptunus Interlong Bio-Technique Business Overview
10.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
10.16 Tonghua Dongbao Pharmaceutical
10.16.1 Tonghua Dongbao Pharmaceutical Basic Information
10.16.2 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
10.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Market Performance
10.16.4 Tonghua Dongbao Pharmaceutical Business Overview
10.16.5 Tonghua Dongbao Pharmaceutical Recent Developments
10.17 Torrent Pharmaceuticals
10.17.1 Torrent Pharmaceuticals Basic Information
10.17.2 Torrent Pharmaceuticals Biotechnological Drugs Product Overview
10.17.3 Torrent Pharmaceuticals Biotechnological Drugs Product Market Performance
10.17.4 Torrent Pharmaceuticals Business Overview
10.17.5 Torrent Pharmaceuticals Recent Developments
11 BIOTECHNOLOGICAL DRUGS MARKET FORECAST BY REGION
11.1 Global Biotechnological Drugs Market Size Forecast
11.2 Global Biotechnological Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biotechnological Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Biotechnological Drugs Market Size Forecast by Region
11.2.4 South America Biotechnological Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biotechnological Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Biotechnological Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Biotechnological Drugs by Type (2026-2033)
12.1.2 Global Biotechnological Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Biotechnological Drugs by Type (2026-2033)
12.2 Global Biotechnological Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Biotechnological Drugs Sales (K MT) Forecast by Application
12.2.2 Global Biotechnological Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biotechnological Drugs
1.2 Key Market Segments
1.2.1 Biotechnological Drugs Segment by Type
1.2.2 Biotechnological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTECHNOLOGICAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biotechnological Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Biotechnological Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTECHNOLOGICAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biotechnological Drugs Product Life Cycle
3.3 Global Biotechnological Drugs Sales by Manufacturers (2020-2025)
3.4 Global Biotechnological Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biotechnological Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biotechnological Drugs Market Competitive Situation and Trends
3.8.1 Biotechnological Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biotechnological Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOTECHNOLOGICAL DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Biotechnological Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTECHNOLOGICAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biotechnological Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biotechnological Drugs Market
5.7 ESG Ratings of Leading Companies
6 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biotechnological Drugs Sales Market Share by Type (2020-2025)
6.3 Global Biotechnological Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Biotechnological Drugs Price by Type (2020-2025)
7 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biotechnological Drugs Market Sales by Application (2020-2025)
7.3 Global Biotechnological Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Biotechnological Drugs Sales Growth Rate by Application (2020-2025)
8 BIOTECHNOLOGICAL DRUGS MARKET SALES BY REGION
8.1 Global Biotechnological Drugs Sales by Region
8.1.1 Global Biotechnological Drugs Sales by Region
8.1.2 Global Biotechnological Drugs Sales Market Share by Region
8.2 Global Biotechnological Drugs Market Size by Region
8.2.1 Global Biotechnological Drugs Market Size by Region
8.2.2 Global Biotechnological Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Biotechnological Drugs Sales by Country
8.3.2 North America Biotechnological Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biotechnological Drugs Sales by Country
8.4.2 Europe Biotechnological Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biotechnological Drugs Sales by Region
8.5.2 Asia Pacific Biotechnological Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biotechnological Drugs Sales by Country
8.6.2 South America Biotechnological Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biotechnological Drugs Sales by Region
8.7.2 Middle East and Africa Biotechnological Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOTECHNOLOGICAL DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Biotechnological Drugs by Region(2020-2025)
9.2 Global Biotechnological Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biotechnological Drugs Production
9.4.1 North America Biotechnological Drugs Production Growth Rate (2020-2025)
9.4.2 North America Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biotechnological Drugs Production
9.5.1 Europe Biotechnological Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biotechnological Drugs Production (2020-2025)
9.6.1 Japan Biotechnological Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biotechnological Drugs Production (2020-2025)
9.7.1 China Biotechnological Drugs Production Growth Rate (2020-2025)
9.7.2 China Biotechnological Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 3SBIO
10.1.1 3SBIO Basic Information
10.1.2 3SBIO Biotechnological Drugs Product Overview
10.1.3 3SBIO Biotechnological Drugs Product Market Performance
10.1.4 3SBIO Business Overview
10.1.5 3SBIO SWOT Analysis
10.1.6 3SBIO Recent Developments
10.2 Anhui Anke Biotechnology
10.2.1 Anhui Anke Biotechnology Basic Information
10.2.2 Anhui Anke Biotechnology Biotechnological Drugs Product Overview
10.2.3 Anhui Anke Biotechnology Biotechnological Drugs Product Market Performance
10.2.4 Anhui Anke Biotechnology Business Overview
10.2.5 Anhui Anke Biotechnology SWOT Analysis
10.2.6 Anhui Anke Biotechnology Recent Developments
10.3 Beijing SL Pharmaceutical
10.3.1 Beijing SL Pharmaceutical Basic Information
10.3.2 Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
10.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Product Market Performance
10.3.4 Beijing SL Pharmaceutical Business Overview
10.3.5 Beijing SL Pharmaceutical SWOT Analysis
10.3.6 Beijing SL Pharmaceutical Recent Developments
10.4 Biotech Pharmaceutical
10.4.1 Biotech Pharmaceutical Basic Information
10.4.2 Biotech Pharmaceutical Biotechnological Drugs Product Overview
10.4.3 Biotech Pharmaceutical Biotechnological Drugs Product Market Performance
10.4.4 Biotech Pharmaceutical Business Overview
10.4.5 Biotech Pharmaceutical Recent Developments
10.5 Cadila Healthcare
10.5.1 Cadila Healthcare Basic Information
10.5.2 Cadila Healthcare Biotechnological Drugs Product Overview
10.5.3 Cadila Healthcare Biotechnological Drugs Product Market Performance
10.5.4 Cadila Healthcare Business Overview
10.5.5 Cadila Healthcare Recent Developments
10.6 Celgen Biopharma
10.6.1 Celgen Biopharma Basic Information
10.6.2 Celgen Biopharma Biotechnological Drugs Product Overview
10.6.3 Celgen Biopharma Biotechnological Drugs Product Market Performance
10.6.4 Celgen Biopharma Business Overview
10.6.5 Celgen Biopharma Recent Developments
10.7 Celltrion
10.7.1 Celltrion Basic Information
10.7.2 Celltrion Biotechnological Drugs Product Overview
10.7.3 Celltrion Biotechnological Drugs Product Market Performance
10.7.4 Celltrion Business Overview
10.7.5 Celltrion Recent Developments
10.8 Dr Reddy?s
10.8.1 Dr Reddy?s Basic Information
10.8.2 Dr Reddy?s Biotechnological Drugs Product Overview
10.8.3 Dr Reddy?s Biotechnological Drugs Product Market Performance
10.8.4 Dr Reddy?s Business Overview
10.8.5 Dr Reddy?s Recent Developments
10.9 GeneScience Pharmaceuticals
10.9.1 GeneScience Pharmaceuticals Basic Information
10.9.2 GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
10.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Product Market Performance
10.9.4 GeneScience Pharmaceuticals Business Overview
10.9.5 GeneScience Pharmaceuticals Recent Developments
10.10 Hisun Pharma
10.10.1 Hisun Pharma Basic Information
10.10.2 Hisun Pharma Biotechnological Drugs Product Overview
10.10.3 Hisun Pharma Biotechnological Drugs Product Market Performance
10.10.4 Hisun Pharma Business Overview
10.10.5 Hisun Pharma Recent Developments
10.11 Jiangsu Sihuan Bioengineering
10.11.1 Jiangsu Sihuan Bioengineering Basic Information
10.11.2 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
10.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Market Performance
10.11.4 Jiangsu Sihuan Bioengineering Business Overview
10.11.5 Jiangsu Sihuan Bioengineering Recent Developments
10.12 Novartis (Sandoz)
10.12.1 Novartis (Sandoz) Basic Information
10.12.2 Novartis (Sandoz) Biotechnological Drugs Product Overview
10.12.3 Novartis (Sandoz) Biotechnological Drugs Product Market Performance
10.12.4 Novartis (Sandoz) Business Overview
10.12.5 Novartis (Sandoz) Recent Developments
10.13 Pfizer (Hospira)
10.13.1 Pfizer (Hospira) Basic Information
10.13.2 Pfizer (Hospira) Biotechnological Drugs Product Overview
10.13.3 Pfizer (Hospira) Biotechnological Drugs Product Market Performance
10.13.4 Pfizer (Hospira) Business Overview
10.13.5 Pfizer (Hospira) Recent Developments
10.14 Shanghai Lansheng Guojian Pharmaceutical
10.14.1 Shanghai Lansheng Guojian Pharmaceutical Basic Information
10.14.2 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
10.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Market Performance
10.14.4 Shanghai Lansheng Guojian Pharmaceutical Business Overview
10.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
10.15 Shenzhen Neptunus Interlong Bio-Technique
10.15.1 Shenzhen Neptunus Interlong Bio-Technique Basic Information
10.15.2 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
10.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Market Performance
10.15.4 Shenzhen Neptunus Interlong Bio-Technique Business Overview
10.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
10.16 Tonghua Dongbao Pharmaceutical
10.16.1 Tonghua Dongbao Pharmaceutical Basic Information
10.16.2 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
10.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Market Performance
10.16.4 Tonghua Dongbao Pharmaceutical Business Overview
10.16.5 Tonghua Dongbao Pharmaceutical Recent Developments
10.17 Torrent Pharmaceuticals
10.17.1 Torrent Pharmaceuticals Basic Information
10.17.2 Torrent Pharmaceuticals Biotechnological Drugs Product Overview
10.17.3 Torrent Pharmaceuticals Biotechnological Drugs Product Market Performance
10.17.4 Torrent Pharmaceuticals Business Overview
10.17.5 Torrent Pharmaceuticals Recent Developments
11 BIOTECHNOLOGICAL DRUGS MARKET FORECAST BY REGION
11.1 Global Biotechnological Drugs Market Size Forecast
11.2 Global Biotechnological Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biotechnological Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Biotechnological Drugs Market Size Forecast by Region
11.2.4 South America Biotechnological Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biotechnological Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Biotechnological Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Biotechnological Drugs by Type (2026-2033)
12.1.2 Global Biotechnological Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Biotechnological Drugs by Type (2026-2033)
12.2 Global Biotechnological Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Biotechnological Drugs Sales (K MT) Forecast by Application
12.2.2 Global Biotechnological Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biotechnological Drugs Market Size Comparison by Region (M USD)
Table 5. Global Biotechnological Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Biotechnological Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Biotechnological Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Biotechnological Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2024)
Table 10. Global Market Biotechnological Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Biotechnological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Biotechnological Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Biotechnological Drugs Sales by Type (K MT)
Table 26. Global Biotechnological Drugs Market Size by Type (M USD)
Table 27. Global Biotechnological Drugs Sales (K MT) by Type (2020-2025)
Table 28. Global Biotechnological Drugs Sales Market Share by Type (2020-2025)
Table 29. Global Biotechnological Drugs Market Size (M USD) by Type (2020-2025)
Table 30. Global Biotechnological Drugs Market Size Share by Type (2020-2025)
Table 31. Global Biotechnological Drugs Price (USD/MT) by Type (2020-2025)
Table 32. Global Biotechnological Drugs Sales (K MT) by Application
Table 33. Global Biotechnological Drugs Market Size by Application
Table 34. Global Biotechnological Drugs Sales by Application (2020-2025) & (K MT)
Table 35. Global Biotechnological Drugs Sales Market Share by Application (2020-2025)
Table 36. Global Biotechnological Drugs Market Size by Application (2020-2025) & (M USD)
Table 37. Global Biotechnological Drugs Market Share by Application (2020-2025)
Table 38. Global Biotechnological Drugs Sales Growth Rate by Application (2020-2025)
Table 39. Global Biotechnological Drugs Sales by Region (2020-2025) & (K MT)
Table 40. Global Biotechnological Drugs Sales Market Share by Region (2020-2025)
Table 41. Global Biotechnological Drugs Market Size by Region (2020-2025) & (M USD)
Table 42. Global Biotechnological Drugs Market Size Market Share by Region (2020-2025)
Table 43. North America Biotechnological Drugs Sales by Country (2020-2025) & (K MT)
Table 44. North America Biotechnological Drugs Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Biotechnological Drugs Sales by Country (2020-2025) & (K MT)
Table 46. Europe Biotechnological Drugs Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Biotechnological Drugs Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Biotechnological Drugs Market Size by Region (2020-2025) & (M USD)
Table 49. South America Biotechnological Drugs Sales by Country (2020-2025) & (K MT)
Table 50. South America Biotechnological Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Biotechnological Drugs Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Biotechnological Drugs Market Size by Region (2020-2025) & (M USD)
Table 53. Global Biotechnological Drugs Production (K MT) by Region(2020-2025)
Table 54. Global Biotechnological Drugs Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Biotechnological Drugs Revenue Market Share by Region (2020-2025)
Table 56. Global Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. North America Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Europe Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. Japan Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. China Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 61. 3SBIO Basic Information
Table 62. 3SBIO Biotechnological Drugs Product Overview
Table 63. 3SBIO Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. 3SBIO Business Overview
Table 65. 3SBIO SWOT Analysis
Table 66. 3SBIO Recent Developments
Table 67. Anhui Anke Biotechnology Basic Information
Table 68. Anhui Anke Biotechnology Biotechnological Drugs Product Overview
Table 69. Anhui Anke Biotechnology Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Anhui Anke Biotechnology Business Overview
Table 71. Anhui Anke Biotechnology SWOT Analysis
Table 72. Anhui Anke Biotechnology Recent Developments
Table 73. Beijing SL Pharmaceutical Basic Information
Table 74. Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
Table 75. Beijing SL Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Beijing SL Pharmaceutical Business Overview
Table 77. Beijing SL Pharmaceutical SWOT Analysis
Table 78. Beijing SL Pharmaceutical Recent Developments
Table 79. Biotech Pharmaceutical Basic Information
Table 80. Biotech Pharmaceutical Biotechnological Drugs Product Overview
Table 81. Biotech Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. Biotech Pharmaceutical Business Overview
Table 83. Biotech Pharmaceutical Recent Developments
Table 84. Cadila Healthcare Basic Information
Table 85. Cadila Healthcare Biotechnological Drugs Product Overview
Table 86. Cadila Healthcare Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Cadila Healthcare Business Overview
Table 88. Cadila Healthcare Recent Developments
Table 89. Celgen Biopharma Basic Information
Table 90. Celgen Biopharma Biotechnological Drugs Product Overview
Table 91. Celgen Biopharma Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. Celgen Biopharma Business Overview
Table 93. Celgen Biopharma Recent Developments
Table 94. Celltrion Basic Information
Table 95. Celltrion Biotechnological Drugs Product Overview
Table 96. Celltrion Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Celltrion Business Overview
Table 98. Celltrion Recent Developments
Table 99. Dr Reddy?s Basic Information
Table 100. Dr Reddy?s Biotechnological Drugs Product Overview
Table 101. Dr Reddy?s Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Dr Reddy?s Business Overview
Table 103. Dr Reddy?s Recent Developments
Table 104. GeneScience Pharmaceuticals Basic Information
Table 105. GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
Table 106. GeneScience Pharmaceuticals Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. GeneScience Pharmaceuticals Business Overview
Table 108. GeneScience Pharmaceuticals Recent Developments
Table 109. Hisun Pharma Basic Information
Table 110. Hisun Pharma Biotechnological Drugs Product Overview
Table 111. Hisun Pharma Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Hisun Pharma Business Overview
Table 113. Hisun Pharma Recent Developments
Table 114. Jiangsu Sihuan Bioengineering Basic Information
Table 115. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
Table 116. Jiangsu Sihuan Bioengineering Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Jiangsu Sihuan Bioengineering Business Overview
Table 118. Jiangsu Sihuan Bioengineering Recent Developments
Table 119. Novartis (Sandoz) Basic Information
Table 120. Novartis (Sandoz) Biotechnological Drugs Product Overview
Table 121. Novartis (Sandoz) Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Novartis (Sandoz) Business Overview
Table 123. Novartis (Sandoz) Recent Developments
Table 124. Pfizer (Hospira) Basic Information
Table 125. Pfizer (Hospira) Biotechnological Drugs Product Overview
Table 126. Pfizer (Hospira) Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Pfizer (Hospira) Business Overview
Table 128. Pfizer (Hospira) Recent Developments
Table 129. Shanghai Lansheng Guojian Pharmaceutical Basic Information
Table 130. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
Table 131. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Shanghai Lansheng Guojian Pharmaceutical Business Overview
Table 133. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 134. Shenzhen Neptunus Interlong Bio-Technique Basic Information
Table 135. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
Table 136. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Shenzhen Neptunus Interlong Bio-Technique Business Overview
Table 138. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 139. Tonghua Dongbao Pharmaceutical Basic Information
Table 140. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
Table 141. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Tonghua Dongbao Pharmaceutical Business Overview
Table 143. Tonghua Dongbao Pharmaceutical Recent Developments
Table 144. Torrent Pharmaceuticals Basic Information
Table 145. Torrent Pharmaceuticals Biotechnological Drugs Product Overview
Table 146. Torrent Pharmaceuticals Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Torrent Pharmaceuticals Business Overview
Table 148. Torrent Pharmaceuticals Recent Developments
Table 149. Global Biotechnological Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Global Biotechnological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Biotechnological Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 152. North America Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Biotechnological Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 154. Europe Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Biotechnological Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 156. Asia Pacific Biotechnological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Biotechnological Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 158. South America Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Biotechnological Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Biotechnological Drugs Sales Forecast by Type (2026-2033) & (K MT)
Table 162. Global Biotechnological Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Biotechnological Drugs Price Forecast by Type (2026-2033) & (USD/MT)
Table 164. Global Biotechnological Drugs Sales (K MT) Forecast by Application (2026-2033)
Table 165. Global Biotechnological Drugs Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biotechnological Drugs Market Size Comparison by Region (M USD)
Table 5. Global Biotechnological Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Biotechnological Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Biotechnological Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Biotechnological Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2024)
Table 10. Global Market Biotechnological Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Biotechnological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Biotechnological Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Biotechnological Drugs Sales by Type (K MT)
Table 26. Global Biotechnological Drugs Market Size by Type (M USD)
Table 27. Global Biotechnological Drugs Sales (K MT) by Type (2020-2025)
Table 28. Global Biotechnological Drugs Sales Market Share by Type (2020-2025)
Table 29. Global Biotechnological Drugs Market Size (M USD) by Type (2020-2025)
Table 30. Global Biotechnological Drugs Market Size Share by Type (2020-2025)
Table 31. Global Biotechnological Drugs Price (USD/MT) by Type (2020-2025)
Table 32. Global Biotechnological Drugs Sales (K MT) by Application
Table 33. Global Biotechnological Drugs Market Size by Application
Table 34. Global Biotechnological Drugs Sales by Application (2020-2025) & (K MT)
Table 35. Global Biotechnological Drugs Sales Market Share by Application (2020-2025)
Table 36. Global Biotechnological Drugs Market Size by Application (2020-2025) & (M USD)
Table 37. Global Biotechnological Drugs Market Share by Application (2020-2025)
Table 38. Global Biotechnological Drugs Sales Growth Rate by Application (2020-2025)
Table 39. Global Biotechnological Drugs Sales by Region (2020-2025) & (K MT)
Table 40. Global Biotechnological Drugs Sales Market Share by Region (2020-2025)
Table 41. Global Biotechnological Drugs Market Size by Region (2020-2025) & (M USD)
Table 42. Global Biotechnological Drugs Market Size Market Share by Region (2020-2025)
Table 43. North America Biotechnological Drugs Sales by Country (2020-2025) & (K MT)
Table 44. North America Biotechnological Drugs Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Biotechnological Drugs Sales by Country (2020-2025) & (K MT)
Table 46. Europe Biotechnological Drugs Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Biotechnological Drugs Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Biotechnological Drugs Market Size by Region (2020-2025) & (M USD)
Table 49. South America Biotechnological Drugs Sales by Country (2020-2025) & (K MT)
Table 50. South America Biotechnological Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Biotechnological Drugs Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Biotechnological Drugs Market Size by Region (2020-2025) & (M USD)
Table 53. Global Biotechnological Drugs Production (K MT) by Region(2020-2025)
Table 54. Global Biotechnological Drugs Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Biotechnological Drugs Revenue Market Share by Region (2020-2025)
Table 56. Global Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. North America Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Europe Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. Japan Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. China Biotechnological Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 61. 3SBIO Basic Information
Table 62. 3SBIO Biotechnological Drugs Product Overview
Table 63. 3SBIO Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. 3SBIO Business Overview
Table 65. 3SBIO SWOT Analysis
Table 66. 3SBIO Recent Developments
Table 67. Anhui Anke Biotechnology Basic Information
Table 68. Anhui Anke Biotechnology Biotechnological Drugs Product Overview
Table 69. Anhui Anke Biotechnology Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Anhui Anke Biotechnology Business Overview
Table 71. Anhui Anke Biotechnology SWOT Analysis
Table 72. Anhui Anke Biotechnology Recent Developments
Table 73. Beijing SL Pharmaceutical Basic Information
Table 74. Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
Table 75. Beijing SL Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Beijing SL Pharmaceutical Business Overview
Table 77. Beijing SL Pharmaceutical SWOT Analysis
Table 78. Beijing SL Pharmaceutical Recent Developments
Table 79. Biotech Pharmaceutical Basic Information
Table 80. Biotech Pharmaceutical Biotechnological Drugs Product Overview
Table 81. Biotech Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. Biotech Pharmaceutical Business Overview
Table 83. Biotech Pharmaceutical Recent Developments
Table 84. Cadila Healthcare Basic Information
Table 85. Cadila Healthcare Biotechnological Drugs Product Overview
Table 86. Cadila Healthcare Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Cadila Healthcare Business Overview
Table 88. Cadila Healthcare Recent Developments
Table 89. Celgen Biopharma Basic Information
Table 90. Celgen Biopharma Biotechnological Drugs Product Overview
Table 91. Celgen Biopharma Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. Celgen Biopharma Business Overview
Table 93. Celgen Biopharma Recent Developments
Table 94. Celltrion Basic Information
Table 95. Celltrion Biotechnological Drugs Product Overview
Table 96. Celltrion Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Celltrion Business Overview
Table 98. Celltrion Recent Developments
Table 99. Dr Reddy?s Basic Information
Table 100. Dr Reddy?s Biotechnological Drugs Product Overview
Table 101. Dr Reddy?s Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Dr Reddy?s Business Overview
Table 103. Dr Reddy?s Recent Developments
Table 104. GeneScience Pharmaceuticals Basic Information
Table 105. GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
Table 106. GeneScience Pharmaceuticals Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. GeneScience Pharmaceuticals Business Overview
Table 108. GeneScience Pharmaceuticals Recent Developments
Table 109. Hisun Pharma Basic Information
Table 110. Hisun Pharma Biotechnological Drugs Product Overview
Table 111. Hisun Pharma Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Hisun Pharma Business Overview
Table 113. Hisun Pharma Recent Developments
Table 114. Jiangsu Sihuan Bioengineering Basic Information
Table 115. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
Table 116. Jiangsu Sihuan Bioengineering Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Jiangsu Sihuan Bioengineering Business Overview
Table 118. Jiangsu Sihuan Bioengineering Recent Developments
Table 119. Novartis (Sandoz) Basic Information
Table 120. Novartis (Sandoz) Biotechnological Drugs Product Overview
Table 121. Novartis (Sandoz) Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Novartis (Sandoz) Business Overview
Table 123. Novartis (Sandoz) Recent Developments
Table 124. Pfizer (Hospira) Basic Information
Table 125. Pfizer (Hospira) Biotechnological Drugs Product Overview
Table 126. Pfizer (Hospira) Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Pfizer (Hospira) Business Overview
Table 128. Pfizer (Hospira) Recent Developments
Table 129. Shanghai Lansheng Guojian Pharmaceutical Basic Information
Table 130. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
Table 131. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Shanghai Lansheng Guojian Pharmaceutical Business Overview
Table 133. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 134. Shenzhen Neptunus Interlong Bio-Technique Basic Information
Table 135. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
Table 136. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Shenzhen Neptunus Interlong Bio-Technique Business Overview
Table 138. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 139. Tonghua Dongbao Pharmaceutical Basic Information
Table 140. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
Table 141. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Tonghua Dongbao Pharmaceutical Business Overview
Table 143. Tonghua Dongbao Pharmaceutical Recent Developments
Table 144. Torrent Pharmaceuticals Basic Information
Table 145. Torrent Pharmaceuticals Biotechnological Drugs Product Overview
Table 146. Torrent Pharmaceuticals Biotechnological Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Torrent Pharmaceuticals Business Overview
Table 148. Torrent Pharmaceuticals Recent Developments
Table 149. Global Biotechnological Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Global Biotechnological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Biotechnological Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 152. North America Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Biotechnological Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 154. Europe Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Biotechnological Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 156. Asia Pacific Biotechnological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Biotechnological Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 158. South America Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Biotechnological Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Biotechnological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Biotechnological Drugs Sales Forecast by Type (2026-2033) & (K MT)
Table 162. Global Biotechnological Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Biotechnological Drugs Price Forecast by Type (2026-2033) & (USD/MT)
Table 164. Global Biotechnological Drugs Sales (K MT) Forecast by Application (2026-2033)
Table 165. Global Biotechnological Drugs Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biotechnological Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biotechnological Drugs Market Size (M USD), 2024-2033
Figure 5. Global Biotechnological Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Biotechnological Drugs Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biotechnological Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biotechnological Drugs Product Life Cycle
Figure 13. Biotechnological Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Biotechnological Drugs Revenue Share by Manufacturers in 2024
Figure 15. Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Biotechnological Drugs Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biotechnological Drugs Revenue in 2024
Figure 18. Industry Chain Map of Biotechnological Drugs
Figure 19. Global Biotechnological Drugs Market PEST Analysis
Figure 20. Global Biotechnological Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biotechnological Drugs Market Share by Type
Figure 27. Sales Market Share of Biotechnological Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Biotechnological Drugs by Type in 2024
Figure 29. Market Size Share of Biotechnological Drugs by Type (2020-2025)
Figure 30. Market Size Share of Biotechnological Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biotechnological Drugs Market Share by Application
Figure 33. Global Biotechnological Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Biotechnological Drugs Sales Market Share by Application in 2024
Figure 35. Global Biotechnological Drugs Market Share by Application (2020-2025)
Figure 36. Global Biotechnological Drugs Market Share by Application in 2024
Figure 37. Global Biotechnological Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biotechnological Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Biotechnological Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biotechnological Drugs Sales Market Share by Country in 2024
Figure 43. North America Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biotechnological Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biotechnological Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biotechnological Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biotechnological Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biotechnological Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biotechnological Drugs Sales Market Share by Country in 2024
Figure 53. Europe Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biotechnological Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biotechnological Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biotechnological Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biotechnological Drugs Market Size Market Share by Region in 2024
Figure 68. China Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biotechnological Drugs Sales and Growth Rate (K MT)
Figure 79. South America Biotechnological Drugs Sales Market Share by Country in 2024
Figure 80. South America Biotechnological Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Biotechnological Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biotechnological Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biotechnological Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biotechnological Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biotechnological Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biotechnological Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biotechnological Drugs Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Biotechnological Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Biotechnological Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Biotechnological Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Biotechnological Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Biotechnological Drugs Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Biotechnological Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biotechnological Drugs Market Size (M USD), 2024-2033
Figure 5. Global Biotechnological Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Biotechnological Drugs Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biotechnological Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biotechnological Drugs Product Life Cycle
Figure 13. Biotechnological Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Biotechnological Drugs Revenue Share by Manufacturers in 2024
Figure 15. Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Biotechnological Drugs Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biotechnological Drugs Revenue in 2024
Figure 18. Industry Chain Map of Biotechnological Drugs
Figure 19. Global Biotechnological Drugs Market PEST Analysis
Figure 20. Global Biotechnological Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biotechnological Drugs Market Share by Type
Figure 27. Sales Market Share of Biotechnological Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Biotechnological Drugs by Type in 2024
Figure 29. Market Size Share of Biotechnological Drugs by Type (2020-2025)
Figure 30. Market Size Share of Biotechnological Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biotechnological Drugs Market Share by Application
Figure 33. Global Biotechnological Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Biotechnological Drugs Sales Market Share by Application in 2024
Figure 35. Global Biotechnological Drugs Market Share by Application (2020-2025)
Figure 36. Global Biotechnological Drugs Market Share by Application in 2024
Figure 37. Global Biotechnological Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biotechnological Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Biotechnological Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biotechnological Drugs Sales Market Share by Country in 2024
Figure 43. North America Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biotechnological Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biotechnological Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biotechnological Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biotechnological Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biotechnological Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biotechnological Drugs Sales Market Share by Country in 2024
Figure 53. Europe Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biotechnological Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biotechnological Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biotechnological Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biotechnological Drugs Market Size Market Share by Region in 2024
Figure 68. China Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biotechnological Drugs Sales and Growth Rate (K MT)
Figure 79. South America Biotechnological Drugs Sales Market Share by Country in 2024
Figure 80. South America Biotechnological Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Biotechnological Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biotechnological Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biotechnological Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biotechnological Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biotechnological Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biotechnological Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biotechnological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biotechnological Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biotechnological Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biotechnological Drugs Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Biotechnological Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Biotechnological Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Biotechnological Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Biotechnological Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Biotechnological Drugs Market Share Forecast by Application (2026-2033)
